Status: current, Defined. Date: 31-Oct 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4471071000168119 | CBD (Satipharm) (cannabidiol 50 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4471081000168116 | CBD (Satipharm) 50 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| CBD (Satipharm) 50 mg capsule | Is a | CBD (Satipharm) | true | Inferred relationship | Some | ||
| CBD (Satipharm) 50 mg capsule | Is a | cannabidiol 50 mg capsule | true | Inferred relationship | Some | ||
| CBD (Satipharm) 50 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| CBD (Satipharm) 50 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| CBD (Satipharm) 50 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1032230143 | |
| CBD (Satipharm) 50 mg capsule | has Australian BoSS | cannabidiol | true | Inferred relationship | Some | 1052193073 | |
| CBD (Satipharm) 50 mg capsule | has intended active ingredient | cannabidiol | true | Inferred relationship | Some | 1052193073 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| CBD (Satipharm) 50 mg capsule, 30 | has TPUU | True | CBD (Satipharm) 50 mg capsule | Inferred relationship | Some | 1949219791 |
| CBD (Satipharm) 50 mg capsule, 30, blister pack | has TPUU | True | CBD (Satipharm) 50 mg capsule | Inferred relationship | Some | 737138002 |
Reference Sets
Trade product unit of use reference set
FHIR